Volume 17, Number 1—January 2011
Dispatch
Serologic Status for Pandemic (H1N1) 2009 Virus, Taiwan
Table
Group, age, y |
Prevaccination GMT (95% CI) |
Prevaccination seroprotection rate, % |
Postvaccination GMT (95% CI) |
Postvaccination seroprotection rate, % |
p value |
Children <5, n = 40) | |||||
HI |
10.4 (9.9–10.9) |
0 |
ND |
ND |
ND |
Adults 20–49, n = 36 | |||||
HI | 12.1 (10.7–13.7) | 2.8 | 12.1 (10.7–13.7) | 2.80 | NS |
MN |
26.3 (20.9–32.8) |
0 |
31.7 (25.0–40.3) |
0 |
<0.05 |
Older adults 50–74, n = 50 | |||||
HI | 16.7 (14.2–19.7) | 16 | 16.7 (14.2–19.7) | 16 | NS |
MN |
59.0 (47.7–72.8) |
20 |
74.6 (60.0–92.9) |
32 |
<0.05 |
Elderly adults >75, n = 50 | |||||
HI | 22.7 (19.5–26.4) | 36 | 23.3 (19.8–27.4) | 38 | 0.159 |
MN |
85.7 (70.8–103.9) |
32 |
107 (89.2–128.5) |
44 |
<0.05 |
*GMT, geometric mean titer; CI, confidence interval; HI, hemagglutination inhibition; ND, not done; NS, not significant. MN, microneutralization. Mean ± SD ages for the 4 groups were 20.0 ± 11.3 mo for children, 34.5 ± 7.5 y for adults, 65 ± 6 y for older adults, and 79 ± 3.3 y for elderly adults. |
1These authors contributed equally to this article.
Page created: June 30, 2011
Page updated: June 30, 2011
Page reviewed: June 30, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.